Ibex Investors’s ResMed RMD Stock Holding History

Ibex Investors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,161	Closed	-$311K	–	227
2018 Q1	$311K	Buy	+3,161	New	+$299K	0.26%	52

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ibex Investors's RMD Position: Q2 2018 in Review

Ibex Investors sold out of ResMed (RMD) in Q2 2018, closing a stake of 3,161 shares — an estimated $311K sold.

Ibex Investors first reported a position in RMD in Q1 2018 and held it in 1 quarter. The position peaked at $311K in Q1 2018. 465 funds tracked by Wall St. Rank hold RMD as of Q2 2018.

Ibex Investors reported no remaining ResMed position as of Q2 2018 after selling out during the quarter.
Ibex Investors sold 3,161 ResMed shares in Q2 2018, an estimated $311K.
Ibex Investors first reported a position in ResMed in Q1 2018 and held it in 1 quarter.
Ibex Investors's ResMed position peaked at $311K in Q1 2018.
465 funds tracked by Wall St. Rank held ResMed as of Q2 2018.

Based on Ibex Investors's 13F filing for Q2 2018, filed 14 Aug 2018.